Research and Breakthroughs

A CHLA team is looking deep into the intestinal lining to uncover potential new treatment targets in IBD.

Neuromuscular scoliosis curves 80 degrees or larger require more resources—and achieve less optimal results.

The research uses clinical trial data to find how often infants with neonatal hypoxic-ischemic encephalopathy have perinatal arterial ischemic strokes.

The novel approach marks a significant step forward in developing CAR T-cell therapy for acute myeloid leukemia.

Children’s Hospital Los Angeles researcher Anna Cushing, MD, collaborated on a study that found U.S. hospitals closed a third of their pediatric inpatient units between 2008 and 2022. The study is a

A clinical trial at CHLA is studying virus-specific T-cell therapy as a potential treatment for newborns with congenital cytomegalovirus.

A multi-center clinical trial demonstrates how new reporting tools help symptom management and intervention for children receiving cancer treatment.

A recent study led by Principal Investigator Michael Goran, PhD, and Rachel Schenker, MD, a Fellow in the CHLA Liver Transplant Program, has found a novel combination of plasma-based biomarkers that

A Children’s Hospital Los Angeles study has found that a virus that infects a common bacteria may lead to accelerated loss of lung function in individuals with cystic fibrosis (CF). The study

Effects on children’s brains from premature birth are more drastic the earlier infants are born and can last until adulthood